Organization | University of Sierra Leone

University of Sierra Leone Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Sierra Leone (1827)

Organization Overview

First Clinical Trial

2015

NCT02380625

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

College of Medicine and Allied Health Sciences | College of Medicine and Allied Health Sciences (COMAHS) | University of Sierra Leone

Active Ingredients

Drugs in Phase 3 Trials (6)

ad26.zebov (Zabdeno) (4 trials)

azithromycin (zithromax) (2 trials)

mva-bn-filo (Mvabea) (3 trials)

pyrimethamine (daraprim) (1 trial)

rvsvdelta-zebov-gp (2 trials)

sulfadoxine (1 trial)

Drugs in Phase 2 Trials (5)

atorvastatin (lipitor) (1 trial)

erlotinib (tarceva) (1 trial)

irbesartan (avapro) (1 trial)

sunitinib (sutent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hemorrhagic Fever, Ebola (Phase 3)

Hemorrhagic Fevers, Viral (Phase 3)

Virus Diseases (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 7
# of Trial APIs: 11